Acalabrutinib (ACP-196): a selective second-generation BTK inhibitor
Jingjing Wu(Zunyi Medical University), Delong Liu(Westchester Medical Center), Mingzhi Zhang(Chinese Academy of Sciences)
Cited by 250
Related Papers
Universal CARs, universal T cells, and universal CAR T cells
|Journal of Hematology & Oncology|2018|303
PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?
|Frontiers in Immunology|2017|296
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42
|Digestive Diseases and Sciences|2011|140
HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment
|Theranostics|2021|140
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
|Journal of Hematology & Oncology|2018|134